---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-25-000062"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T01:55:22.822294+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# West Pharma beats Q2, raises FY 2025 guidance; declares Q4 dividend

## Summary
- Net sales $766.5M (+9.2% YoY); diluted EPS $1.82 vs $1.51; adjusted EPS $1.84 vs $1.52.
- FY 2025 net sales guidance raised to $3.04-3.06B (from $2.945-2.975B); adjusted EPS raised to $6.65-6.85.
- Proprietary Products sales $619.8M (+10.7%); HVP components up 11.3% driven by GLP-1 elastomer growth.
- Board declares Q4 dividend $0.22/share, payable Nov 19, record Nov 12.
- First-half 2025 free cash flow $160M (from $92.4M); repurchased 552,593 shares for $134M.

## SEC filing metadata
- accession: 0000105770-25-000062
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577025000062/0000105770-25-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577025000062/wst-20250724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-25-000062
- JSON: https://secwatch.observer/filing/0000105770-25-000062.json
- Plain text: https://secwatch.observer/filing/0000105770-25-000062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.